New Key Statistics Module, Z-Score and F-Score
NAS:ZVRA Key Ratios
Market Cap $ M | 194.62 |
Enterprise Value $ M | 187.03 |
P/E(ttm) | -- |
PE Ratio without NRI | -- |
Forward PE Ratio | -- |
Price/Book | 3.97 |
Price/Sales | 6.37 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) $ M | 28.00 |
EPS (TTM) $ | -1.35 |
Beneish M-Score | 34.49 |
10-y EBITDA Growth Rate % | 34.60 |
5-y EBITDA Growth Rate % | 54.00 |
y-y EBITDA Growth Rate % | -- |
EV-to-EBIT | -3.83 |
EV-to-EBITDA | -4.04 |
PEG | -- |
Shares Outstanding M | 41.85 |
Net Margin (%) | -181.76 |
Operating Margin % | -204.11 |
Pre-tax Margin (%) | -181.64 |
Quick Ratio | 2.10 |
Current Ratio | 2.10 |
ROA % (ttm) | -37.72 |
ROE % (ttm) | -80.02 |
ROIC % (ttm) | -99.25 |
Dividend Yield % | -- |
Altman Z-Score | -3.33 |
ZVRA Number of Guru Trades
ZVRA Volume of Guru Trades
Gurus Latest Trades with NAS:ZVRA
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:ZVRA is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Zevra Therapeutics Inc Insider Transactions
No Available Data
News about NAS:ZVRA
Total 0- 1